Yang Jiaqi, Zhang Zhenghao, Ma Fang, Xia Tongtong, Liu Honglin, Xiong Jiantuan, Ma Shengchao, Jiang Yideng, Hao Yinju
NHC Key Laboratory of Metabolic Cardiovascular Diseases Research, Yinchuan 750004, China.
NHC Key Laboratory of Metabolic Cardiovascular Diseases Research, Department of Otolaryngology, People's Hospital of Ningxia Hui Autonomous Regin, Yinchuan 750004, China.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2025 Jul;41(7):577-584.
Objective To investigate the effect and mechanism of Efferocytosis Relatived LncRNA (EFRL) on homocysteine-induced atherosclerosis in macrophage efferocytosis. Methods RAW264.7 cells were cultured in vitro, and the Control group (0 μmol/L Hcy) and Hcy intervention group (100 μmol/L Hcy) were set up. After GapmeR transfection of macrophages with Hcy intervention, EFRL knockdown negative control group (Hcy combined with LNA-NC) and EFRL knockdown group (Hcy combined with LNA-EFRL) were set up. High-throughput sequencing was applied for different expression of LncRNA MSTRG. 88917.16 (EFRL), UCSC was used to analyze its conservation, CPC and CPAT were used to analyze its ability to encode proteins, and GO and KEGG were used to analyze related biological functions. The localization of LncRNA EFRL in macrophages was analyzed by nucleoplasmic separation and RNA-FISH. Quantitative real-time PCR was used to detect the expression levels of LncRNA EFRL and its target gene SPAST in Hcy-treated macrophages. The apoptosis rate of Jurkat cells induced by UV was detected by flow cytometry. In vitro efferocytosis assay combined with immunofluorescence technique was used to analyze macrophage efferocytosis. ELISA was used to detect the levels of interleukin 1β(IL-1β) and IL-18. Results The new LncRNA MSTRG.88917.16 was identified and named EFRL(Efferocytosis Relatived LncRNA). UCSC, CPC and CPAT analyses showed that LncEFRL is highly conserved and does not have the ability to encode proteins. GO and KEGG analyses suggested that LncEFRL may be involved in macrophage efferocytosis. LncRNA EFRL was localized in the nucleus of macrophages as determined by nucleoplasmic separation and RNA-FISH. In comparison to the Control group, the expression levels of LncRNA EFRL and its target gene SPAST in the Hcy group were increased. In comparison to the Control group (0 min), the apoptosis rate of the experimental group (15, 30 min) Annexin V is more than 85%. Compared with Hcy combined with LNA-NC group, Hcy combined with LNA-EFRL group had enhanced macrophage efferocytosis and reduced levels of inflammatory factors. Compared with Hcy combined with LNA-NC group, the expression level of SPAST in Hcy combined with LNA-EFRL group was decreased. Conclusion Inhibition of EFRL expression can alleviate the process of Hcy inhibiting macrophage efferocytosis, and the mechanism is related to the regulation of the downstream target gene SPAST by EFRL.
目的 探讨吞噬相关长链非编码RNA(EFRL)对同型半胱氨酸诱导巨噬细胞吞噬作用中动脉粥样硬化的影响及机制。方法 体外培养RAW264.7细胞,设置对照组(0 μmol/L同型半胱氨酸)和同型半胱氨酸干预组(100 μmol/L同型半胱氨酸)。对同型半胱氨酸干预的巨噬细胞进行GapmeR转染后,设置EFRL敲低阴性对照组(同型半胱氨酸联合LNA-NC)和EFRL敲低组(同型半胱氨酸联合LNA-EFRL)。应用高通量测序分析长链非编码RNA MSTRG.88917.16(EFRL)的差异表达,利用UCSC分析其保守性,用CPC和CPAT分析其编码蛋白质的能力,用GO和KEGG分析相关生物学功能。通过核质分离和RNA-FISH分析LncRNA EFRL在巨噬细胞中的定位。采用定量实时PCR检测同型半胱氨酸处理的巨噬细胞中LncRNA EFRL及其靶基因痉挛性截瘫蛋白(SPAST)的表达水平。通过流式细胞术检测紫外线诱导的Jurkat细胞凋亡率。采用体外吞噬试验结合免疫荧光技术分析巨噬细胞吞噬作用。用ELISA检测白细胞介素1β(IL-1β)和IL-18水平。结果 鉴定出新型长链非编码RNA MSTRG.88917.16并命名为EFRL(吞噬相关长链非编码RNA)。UCSC、CPC和CPAT分析表明LncEFRL高度保守且无编码蛋白质的能力。GO和KEGG分析提示LncEFRL可能参与巨噬细胞吞噬作用。通过核质分离和RNA-FISH确定LncRNA EFRL定位于巨噬细胞核。与对照组相比,同型半胱氨酸组中LncRNA EFRL及其靶基因SPAST的表达水平升高。与对照组(0分钟)相比,实验组(15、30分钟)膜联蛋白V凋亡率超过85%。与同型半胱氨酸联合LNA-NC组相比,同型半胱氨酸联合LNA-EFRL组巨噬细胞吞噬作用增强,炎症因子水平降低。与同型半胱氨酸联合LNA-NC组相比,同型半胱氨酸联合LNA-EFRL组中SPAST的表达水平降低。结论 抑制EFRL表达可减轻同型半胱氨酸抑制巨噬细胞吞噬作用的过程,其机制与EFRL对下游靶基因SPAST的调控有关。